Tumor volume doubling time of pulmonary metastases predicts overall survival and can guide the initiation of multikinase inhibitor therapy in patients with metastatic, follicular cell-derived thyroid carcinoma-Reference-Cited by-同舟云学术

Tumor volume doubling time of pulmonary metastases predicts overall survival and can guide the initiation of multikinase inhibitor therapy in patients with metastatic, follicular cell-derived thyroid carcinoma

Published:2017-04-03 Issue:15 Volume:123 Page:2955-2964
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Sabra Mona M.¹^ORCID,Sherman Eric J.²^ORCID,Tuttle R. Michael¹

Affiliation:

1. Endocrinology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill-Cornell College of Medicine; New York New York

2. Head and Neck Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill-Cornell College of Medicine; New York New York

Funder

National Institutes of Health

National Cancer Institute Cancer Center

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference20 articles.

1. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995;Hundahl;Cancer,1998

2. Time course and predictors of structural disease progression in pulmonary metastases arising from follicular cell-derived thyroid cancer;Sabra;Thyroid,2016

3. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy;Durante;J Clin Endocrinol Metab,2006

4. Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning;Robbins;J Clin Endocrinol Metab,2006

5. Skeletal-related events due to bone metastases from differentiated thyroid cancer;Farooki;J Clin Endocrinol Metab,2012

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radioactive Iodine Therapy in Differentiated Thyroid Cancer: An Update on Dose Recommendations and Risk of Secondary Primary Malignancies;Seminars in Nuclear Medicine;2024-07

2. Tumor Growth Kinetics Based on Initial Tumor Volume Doubling Time in Active Surveillance of Low-Risk Papillary Thyroid Carcinoma;Thyroid®;2024-07-01

3. Prognostic value of tumor volume doubling time in lung-metastatic adenoid cystic carcinoma;Oral Oncology;2024-04

4. First Use of AXL Targeting in Metastatic, Refractory, Adenoid Cystic Carcinoma: A Case Report;JCO Precision Oncology;2024-04

5. Utility and optimal management of planned drug holidays during lenvatinib treatment in patients with unresectable differentiated thyroid cancer: a real-world multi-center study;Endocrine;2024-02-27